| 000 | 01532 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517183708.0 | ||
| 264 | 0 | _c20180727 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1543-8392 | ||
| 024 | 7 |
_a10.1021/acs.molpharmaceut.7b00775 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColas, Claire | |
| 245 | 0 | 0 |
_aChemical Modulation of the Human Oligopeptide Transporter 1, hPepT1. _h[electronic resource] |
| 260 |
_bMolecular pharmaceutics _c12 2017 |
||
| 300 |
_a4685-4693 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aBiological Transport, Active _xdrug effects |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aOligopeptides _xchemistry |
| 650 | 0 | 4 |
_aPeptide Transporter 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProdrugs _xchemistry |
| 700 | 1 | _aMasuda, Masayuki | |
| 700 | 1 | _aSugio, Kazuaki | |
| 700 | 1 | _aMiyauchi, Seiji | |
| 700 | 1 | _aHu, Yongjun | |
| 700 | 1 | _aSmith, David E | |
| 700 | 1 | _aSchlessinger, Avner | |
| 773 | 0 |
_tMolecular pharmaceutics _gvol. 14 _gno. 12 _gp. 4685-4693 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.molpharmaceut.7b00775 _zAvailable from publisher's website |
| 999 |
_c27762712 _d27762712 |
||